CXCL9: evidence and contradictions for its role in tumor progression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL9: evidence and contradictions for its role in tumor progression
Authors
Keywords
-
Journal
Cancer Medicine
Volume 5, Issue 11, Pages 3246-3259
Publisher
Wiley
Online
2016-10-13
DOI
10.1002/cam4.934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients
- (2016) Zhenqian Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites
- (2016) M Wadwa et al. Mucosal Immunology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CXCR3 ligands in disease and therapy
- (2015) Katrien Van Raemdonck et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Treg-cell depletion promotes chemokine production and accumulation of CXCR3+conventional T cells in intestinal tumors
- (2015) Paulina Akeus et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis
- (2015) Ahmed A. Ejaeidi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma
- (2015) Rui-Xian Liu et al. HEPATOLOGY
- From mice to humans: developments in cancer immunoediting
- (2015) Michele W.L. Teng et al. JOURNAL OF CLINICAL INVESTIGATION
- Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis
- (2015) Laëtitia Basset et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification
- (2015) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- Microenvironmental regulation of therapeutic response in cancer
- (2015) Florian Klemm et al. TRENDS IN CELL BIOLOGY
- Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification
- (2015) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease
- (2015) E. Clancy-Thompson et al. Cancer Immunology Research
- Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma
- (2014) M. A. Mir et al. BLOOD
- Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFN
- (2014) R.-S. Soong et al. CLINICAL CANCER RESEARCH
- Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice
- (2014) Aki Ikeda et al. HEPATOLOGY
- Twelve Serum Proteins Progressively Increase With Disease Stage in Squamous Cell Cervical Cancer Patients
- (2014) Wenbo Zhi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2
- (2014) Xiaoqin Lan et al. JOURNAL OF MOLECULAR HISTOLOGY
- Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling
- (2014) Shuai Hu et al. Molecular Oncology
- The Probiotic Mixture VSL#3 Dampens LPS-Induced Chemokine Expression in Human Dendritic Cells by Inhibition of STAT-1 Phosphorylation
- (2014) Rob Mariman et al. PLoS One
- CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes
- (2014) Oksana Kowalczuk et al. TUMOR BIOLOGY
- IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
- (2013) Hayato Maruoka et al. ANNALS OF HEMATOLOGY
- MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis
- (2013) Damian Tworek et al. Archives of Medical Science
- Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
- (2013) N Chaput et al. BRITISH JOURNAL OF CANCER
- CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
- (2013) D Bedognetti et al. BRITISH JOURNAL OF CANCER
- IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
- (2013) J. L. Wong et al. CANCER RESEARCH
- Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response
- (2013) Lára Hannesdóttir et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Activator protein 1 transcription factor fos-related antigen 1 (fra-1) is dispensable for murine liver fibrosis, but modulates xenobiotic metabolism
- (2013) Sebastian C. Hasenfuss et al. HEPATOLOGY
- Suppression of T-Cell Chemokines by Porphyromonas gingivalis
- (2013) Catherine E. Jauregui et al. INFECTION AND IMMUNITY
- Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma
- (2013) Kai-Ping Chang et al. ORAL ONCOLOGY
- Clinically Relevant Dimer Interface Mutants of STAT1 Transcription Factor Exhibit Differential Gene Expression
- (2013) Julia Staab et al. PLoS One
- Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma
- (2013) Li-Jen Hsin et al. PLoS One
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice
- (2012) Hacer Sahin et al. HEPATOLOGY
- Recruitment of Natural Killer Cells in Advanced Stages of Endogenously Arising B-cell Lymphoma
- (2012) Margarethe Przewoznik et al. JOURNAL OF IMMUNOTHERAPY
- Low Herpesvirus Entry Mediator (HVEM) Expression on Dermal Fibroblasts Contributes to a Th2-Dominant Microenvironment in Advanced Cutaneous T-Cell Lymphoma
- (2012) Tomomitsu Miyagaki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Invasion-associated genes identified by gene expression profiling in extranodal natural killer/T-cell lymphoma, nasal type
- (2012) Jian-Bo Yu et al. LEUKEMIA & LYMPHOMA
- Temporally designed treatment of melanoma cells by ATRA and polyI
- (2012) Attila Szabo et al. MELANOMA RESEARCH
- Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
- (2012) Minu K. Srivastava et al. PLoS One
- Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
- (2011) X.-J. Yan et al. BLOOD
- A Th1 cytokine–enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells
- (2011) Archana Thakur et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
- (2011) M. Hong et al. CANCER RESEARCH
- Role of CXCR3 Ligands in IL-7/IL-7R -Fc-Mediated Antitumor Activity in Lung Cancer
- (2011) A. Andersson et al. CLINICAL CANCER RESEARCH
- Predicting Ulcerative Colitis-Associated Colorectal Cancer Using Reverse-Transcription Polymerase Chain Reaction Analysis
- (2011) Toshiaki Watanabe et al. Clinical Colorectal Cancer
- CXCR3 ligands: redundant, collaborative and antagonistic functions
- (2011) Joanna R Groom et al. IMMUNOLOGY AND CELL BIOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Tumour-loaded α-type 1-polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia Produce a Superior NK-, NKT- and CD8+ T Cell-attracting Chemokine Profile
- (2011) Karin Gustafsson et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations
- (2010) Hsei-Wei Wang et al. BMC GENOMICS
- Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening
- (2010) E Ruiz-Garcia et al. BRITISH JOURNAL OF CANCER
- CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells
- (2010) S Amatschek et al. BRITISH JOURNAL OF CANCER
- Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
- (2010) P. Sreekanthreddy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment
- (2010) A. D. Pardee et al. CANCER RESEARCH
- Chemokine receptor CXCR3 promotes growth of glioma
- (2010) Che Liu et al. CARCINOGENESIS
- Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
- (2010) Daniel Venetz et al. INTERNATIONAL JOURNAL OF CANCER
- The Cell-Specific Induction of CXC Chemokine Ligand 9 Mediated by IFN- in Microglia of the Central Nervous System Is Determined by the Myeloid Transcription Factor PU.1
- (2010) S. L. Ellis et al. JOURNAL OF IMMUNOLOGY
- Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation
- (2010) Eun Yong Chung et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
- (2010) Dagmar Berghuis et al. JOURNAL OF PATHOLOGY
- α-Viniferin Suppresses the Signal Transducer and Activation of Transcription-1 (STAT-1)–Inducible Inflammatory Genes in Interferon-γ–Stimulated Macrophages
- (2010) Eun Yong Chung et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum
- (2010) M. Müller et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- An essential role for DNA methyltransferase 3a in melanoma tumorigenesis
- (2009) Tao Deng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma
- (2009) A Birgersdotter et al. BRITISH JOURNAL OF CANCER
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
- (2009) Hermann E. Wasmuth et al. GASTROENTEROLOGY
- Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
- (2009) Bernhard Mlecnik et al. GASTROENTEROLOGY
- Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen
- (2009) V. L. Martins et al. JOURNAL OF CELL SCIENCE
- Monokine Induced by Interferon γ (IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves’ Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists
- (2009) Alessandro Antonelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Dysregulation of CXCL9 and reduced tumor growth in Egr-1 deficient mice
- (2009) Giuseppe Caso et al. Journal of Hematology & Oncology
- IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer
- (2009) A. Andersson et al. JOURNAL OF IMMUNOLOGY
- HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-κB
- (2009) Li-Min Xia et al. VIROLOGY
- Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy
- (2008) Katja Specht et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
- Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
- (2008) R. Muthuswamy et al. CANCER RESEARCH
- Liver Myofibroblasts Regulate Infiltration and Positioning of Lymphocytes in Human Liver
- (2008) Andrew P. Holt et al. GASTROENTEROLOGY
- Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin
- (2008) Joerg Wenzel et al. INTERNATIONAL JOURNAL OF CANCER
- Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+T cells in lymphocyte-rich gastric carcinoma
- (2008) H Ohtani et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search